Geovax to present data on geo-cm04s1, a next generation covid-19 vaccine, at the world vaccine congress

Atlanta, ga, march 28, 2024 (globe newswire) -- via newmediawire – geovax labs, inc. (nasdaq: govx), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its chief scientific officer, mark newman, phd, will present data on geo-cm04s1, the company's next-generation covid-19 vaccine candidate, during the upcoming 24th annual world vaccine congress taking place in washington, dc on april 1-4, 2024.
GOVX Ratings Summary
GOVX Quant Ranking